NCT03906435Recruiting
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
Parental Perception of Child Vulnerability in the NICU and Development Outcomes: A Randomized Control Trial Preventative Intervention With Cognitive Behavioral Therapy
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 19 Mar 2019
- Start date
- 15 Apr 2019
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Schizophrenia
- NCT number
- NCT03906435
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 15 Apr 2019 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Child Protective Services (CPS) involvement or foster care placement -- Prior enrollment in this PreVNT study for an older sibling.
Other
- Significant congenital anomalies
Who the study is looking for
- Born at Parkland Hospital
- English or Spanish speaking mother +/- father
- ≤ 30.6 weeks gestation at birth
- Survival to 33 weeks gestation
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Parkland Health & Hospital System Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.